| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avidity Biosciences, Inc. (RNA) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. RNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 283.4K | $3.67M | - | |
| Other | 205.0K | $2.65M | - | |
| Other | 116.9K | $1.51M | - | |
| Other | 91.6K | $1.19M | - | |
| Other | 79.0K | $1.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sale+OE | 5,875 | $32.16 | $188,918.26 | -10.4% | |
| Jan 22, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sell | 9,411 | $29.53 | $277,912.09 | -4.0% | |
| Jan 21, 2025 | Levin Arthur A | Director | Sell | 1,872 | $28.60 | $53,536.77 | -12.6% | |
| Jan 21, 2025 | MacLean Michael F | Chief Financial Officer | Sell | 3,287 | $28.59 | $93,985.36 | -1.5% | |
| Jan 21, 2025 | McCarthy Teresa | Chief Human Resources Officer | Sell | 2,959 | $28.59 | $84,611.50 | -1.4% | |
| Jan 21, 2025 | Flanagan W. Michael | Chief Scientific Officer | Sell | 5,672 | $28.60 | $162,191.97 | -3.0% | |
| Jan 21, 2025 | Boyce Sarah | President And CEO | Sell | 10,397 | $28.59 | $297,291.42 | -1.5% | |
| Jan 21, 2025 | Hughes Steven George | Chief Medical Officer | Sell | 3,947 | $28.59 | $112,856.48 | -2.3% | |
| Dec 18, 2024 | Flanagan W. Michael | Csto | Sell | 12,742 | $32.66 | $416,153.72 | -14.9% | |
| Dec 18, 2024 | MacLean Michael F | Chief Financial Officer | Sell | 11,151 | $32.66 | $364,191.66 | -11.9% |